Inzy earnings
Web14 apr. 2024 · RenovoRx (NASDAQ:RNXT – Get Rating) and Inozyme Pharma (NASDAQ:INZY – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, analyst recommendations, institutional ownership and … Web31 mrt. 2024 · INZY Inozyme Pharma, Inc. Earnings Surprise 745 followers $5.73 1.04 ( +22.17%) 4:00 PM 03/31/23 NASDAQ $USD Post-Market: $5.67 -0.06 (-1.05%) 7:56 PM Summary Ratings Financials Earnings...
Inzy earnings
Did you know?
WebOn Invalid Date, Inozyme Pharma (NASDAQ: INZY) reported Q4 2024 earnings per share (EPS) of -$0.42, up 46.84% year over year. Total Inozyme Pharma earnings for the quarter were -$18.54 million. In the same quarter last year, Inozyme Pharma's earnings per share (EPS) was -$0.79. WebYou can buy and sell Inozyme Pharma (INZY) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. …
Web27 mrt. 2024 · Inozyme Pharma, Inc. (NASDAQ:INZY – Get Rating) – Equities researchers at Wedbush upped their Q1 2024 earnings estimates for shares of Inozyme Pharma in a report issued on Wednesday, March 22nd. Web16 mrt. 2024 · This suggests that analysts have very recently bumped up their estimates for INZY, giving the stock a Zacks Earnings ESP of +12.11% heading into earnings season. Inozyme Pharma, Inc. Price...
Web24 mrt. 2024 · INZY support price is $3.10 and resistance is $3.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INZY stock will trade within this expected range on the day. Web27 mrt. 2024 · Shares of NASDAQ:INZY opened at $3.60 on Monday. The company has a debt-to-equity ratio of 0.03, a current ratio of 8.93 and a quick ratio of 11.11. Inozyme Pharma has a 1-year low of $0.99 and a ...
WebINZY Stock 12 Months Forecast. $15.25. (178.28% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Inozyme Pharma in the last 3 months. The average …
Web5 uur geleden · BOSTON, April 14, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. I INZY, a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Yves Sabbagh, Ph.D., the company’s senior vice president and chief … china shop online ukWebInozyme Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. INZY updated stock price target summary. Dow Jones, a News Corp company About WSJ china shopping bag supermarketWeb12 apr. 2024 · Shares of Lithia Motors stock opened at $227.63 on Wednesday. The firm has a market capitalization of $6.22 billion, a P/E ratio of 5.17, a price-to-earnings-growth ratio of 1.51 and a beta of 1. ... grammar practice for 5th gradeWeb22 mrt. 2024 · INZY has generated -$2.26 earnings per share over the last four quarters. What is Inozyme Pharma's EPS forecast for next year? Inozyme Pharma's earnings are … grammar practice book mcgraw hillWebEarnings Summary For their last quarter, Inozyme Pharma (INZY) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive... grammar practice for class 10 cbseWeb6 apr. 2024 · The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. Sector Health Care Industry Biotechnology Employees 56 Founded … grammar practice for class 10Web22 mrt. 2024 · The following information was filed by Inozyme Pharma, Inc. (INZY) on Wednesday, March 22, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the … china shopping mall lighting